Outcomes

Ferrante ND, Hubbard RA, Weinfurtner K, Mezina AI, Newcomb CW, Furth EE, Bhattacharya D, Njei B, Taddei TH, Singal A, Hoteit MA, Park LS, Kaplan[...]

By sjmartinez • May 7, 2025

Maqsood MH, Zhang RS, Rosenfeld K, Moriarty JM, Rosovsky RP, Horowitz JM, Alviar CL, Bangalore S. Do Pulmonary Embolism Response Teams in Acute Pulmonary Embolism[...]

By sjmartinez • April 22, 2025

Lo CH, Verma R, Amin R, Manne V, Saab S. Rural-Urban Disparities in Mortality Related to Alcohol-Associated Liver Disease by Race/Ethnicity in the United States[...]

By sjmartinez • April 15, 2025

Gunes I, Bernstein EJ, Cowper SE, Panse G, Pradhan N, Camacho LD, Page N, Bundschuh E, Williams A, Carns M, Aren K, Fantus S, Volkmann[...]

By sjmartinez • April 12, 2025

Schaenman JM, Pickering H, Reed EF, Rossetti M, Seligman B, Weigt SS, Shino M, Sayah D, Belperio J, Hu A, Prosper A, Ruchalski K, Ardehali[...]

By sjmartinez • March 27, 2025

Sedrak MS, Asnani A. Frailty: Can a Biological Aging Marker Enhance Precision Risk Assessment of Cancer Therapy Cardiotoxicity? JACC CardioOncol. 2025 Feb;7(2):122-124. doi: 10.1016/j.jaccao.2025.01.004. PMID:[...]

By sjmartinez • February 19, 2025

Patel S, Raman VK, Faselis C, Fonarow GC, Lam PH, Ahmed AA, Heidenreich PA, Anker SD, Deedwania P, Morgan CJ, Zhang S, Moore H, Rangaswami[...]

By sjmartinez • February 8, 2025

Jaiswal V, Hanif M, Mashkoor Y, Jaiswal A, Prasad T, Rajak K, Khan MS, Mentz RJ, Fonarow GC. Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes[...]

By sjmartinez • January 16, 2025

Huston-Paterson HH, Mao YV, Tseng CH, Kim J, Chen DW, Wu JX, Yeh MW. The Relationship Between Hospital Safety-Net Burden on Outcomes for High-Volume Thyroid[...]

By sjmartinez • November 14, 2024